Immunohistochemistry for the diagnosis of skin tumours;Apport de l'immunohistochimie au diagnostic des tumeurs cutanees

Annales de Dermatologie et de Venereologie

Volumn 125, Issue 5, 1998, Pages 354-369

  Kanitakis, J ^a   Faure, M ^a   Claudy, A ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOHISTOCHEMISTRY; METASTASIS; MUSCLE TUMOR; NERVE TUMOR; PROGNOSIS; REVIEW; SKIN TUMOR; VASCULAR TUMOR;

DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOHISTOCHEMISTRY; PROGNOSIS; SKIN; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0031840185     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (143)

1. Bhan A. Diagnostic strategies based on differentiation antigens. In: Colvin R, Bhan A, McCluskey R (eds) Diagnostic Immunopathology. New York: Raven Press 1995:455-78.
2. Kanitakis J, Thivolet J. Les immunomarquages en histopathologie cutanée. Principes et applications pratiques. Ann Pathol 1987;7:79-97.
3. Wick M, Swanson P, Ritter J, Fitzgibbon J. The immunohistochemistry of cutaneous neoplasia: a practical perspective. J Cutan Pathol 1993;20:481-97.
4. Googe P, Byers H, Mihm M. Skin tumors. In: Colvin R, Bhan A, McCluskey R. Diagnostic Immunopathology. 2nd edn, Raven Press, New York 1995:535-49.
5. Nadji M. Immunoperoxidase techniques. I. Facts and artifacts. Am J Dermatopathol 1986;8:32-6.
6. Kamarashev J. Immunohistochemical techniques for light microscopy. In: Kanitakis J, Vassileva S, Woodley D (eds). Diagnostic Immunohistochemistry of the Skin. Chapman & Hall Med., Londres, 1998,3-18 .
7. True L. (ed). Atlas of Diagnostic Immunohistopathology. JB Lippincott, Philadelphia, 1990.
8. Kanitakis J. Immunohistochimie de la peau humaine normale. In: Nicolas JF, Thivolet J (eds), Immunodermatologie. European Journal of Dermatology book series, J. Libbey, Eurotext 1997;135-48.
9. Wallace M, Smoller B. Immunohistochemistry in diagnostic dermatopathology. J Am Acad Dermatol 1996;34:163-83.
10. Moll R, Franke W, Schiller D, Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982;31:11-24.
11. Eichner R Bonitz P, Sun TT. Classification of epidermal keratins according to their immunoreactivity, isoelectric point, and mode of expression. J Cell Biol 1984;98:1388-96.
12. Smack D, Korge B, James W. Keratin and keratinization. J Am Acad Dermatol 1994;30;85-102.
13. Kanitakis J. Les anticorps anti-cytosquelette et leur intérêt en histopathologie cutanée. Ann Dermatol Venereol 1989;116:431-6.
14. Cooper D, Schermer A, Sun TT. Biology of disease: classification of human epithelia and their neoplasms using monoclonal antibodies to keratins: strategies, applications and limitations. Lab Invest 1985;52:243-55.
15. Debus E, Moll R, Franke W et al. Immunohistochemical distinction of human carcinomas by cytokeratin typing with monoclonal antibodies. Am J Pathol 1984;114:121-30.
16. Osborn M, Weber K. Biology of disease: tumor diagnosis by intermediate filament typing. Lab Invest 1983;48:372-94.
17. Thomas P, Battifora H. Keratin versus epithelial membrane antigen in tumor diagnosis. An immunohistochemical comparison of five monoclonal antibodies. Hum Pathol 1987;18:728-34.
18. Thomas P, Said JW, Nash G, Banks-Schlegel S. Profiles of keratin proteins in basal and squamous cell carcinomas of the skin. Lab Invest 1984;50:36-41.
19. Moll R, Cowin P, Kapprell H, Franke W. Desmosomal proteins: new markers for identification and classification of tumors. Lab Invest 1986;54:4-25.
20. Said J, Sassoon A, Shintaku I, Banks-Schlegel S. Involucrin in squamous and basal cell carcinomas of the skin. J Invest Dermatol 1984;82:449-52.
21. Kanitakis J, Ramirez-Bosca A, Réano A, Viac J, Roche P, Thivolet J. Filaggrin expression in normal and pathological skin. Virchows Arch A 1988;412:375-82.
22. Heyderman E, Graham R, Chapman D et al. Epithelial markers in primary skin cancer: an imunoperoxidase study of epithelial membrane antigen and carcinoembryonic antigen in 65 primary skin carcinomas. Histopathol 1984;8:423-34.
23. Azumi N, Battifora H. The distribution of vimentin and keratin in epithelial and non-epithelial neoplasms: a comprehensive immunohistochemical study on formalin and alcohol fixed tumors. Am J Clin Pathol 1987;88:286-96.
24. McNutt M, Bolen J, Gown A et al. Coexpression of intermediate filaments in human epithelial neoplasms. Ultrastruct Pathol 1985;9:31-43.
25. Krunic A, Garrod D, Smith N, Orchard G, Cvijetic O. Differential expression of desmosomal glycoproteins in keratoacanthoma and squamous cell carcinoma of the skin. Acta Derm Venereol (Stockh) 1996;76:394-8.
26. Reed W, Oppedal B, Eeg Larsen T. Immunohistology is valuable in distinguishing between Paget's disease, Bowen's disease and superficial spreading malignant melanoma. Histopathology 1990;16:583-8.
27. Smoller B, Van de Rijn M, Lebrun D, Warnke R. bcl-2 expression reliably distinguishes trichoepitheliomas from basal cell carcinomas. Br J Dermatol 1994;131:28-31.
28. Kirchman T, Prieto V, Smoller B. CD34 staining pattern distinguishes basal cell epithelioma from trichoepithelioma. Arch Dermatol 1994;130:589-92.
29. Tellechea O, Reis J, Domingues J, Poiares-Baptista A. Monoclonal antibody Ber-P4 distinguishes basal-cell carcinoma from squamous cell carcinoma of the skin. Am J Dermatopathol 1993;15:452-5.
30. Kanitakis J. Immunohistochimie des tumeurs annexielles de la peau. Ann Pathol 1992;92:160-4.
31. Wick M, Swanson, P. Cutaneous Adnexal Tumors. A Guide to Pathologic Diagnosis. American Society of Clinical Pathologists Press, Chicago, 1991.
32. Mazoujian G, Pinkus G, Davis S. Immunohistochemistry of a breast gross cystic disease fluid protein (GCDFP-15): a marker of apocrine epithelium and breast carcinoma with apocrine features. Am J Pathol 1983;110:105-11.
33. Mazoujian G, Margolis R. Immunohistochemistry of gross cystic disease fluid protein (GCDFP-15) in 65 benign sweat gland tumors of the skin. Am J Dermatopathol 1988;10:28-35.
34. Kanitakis J, Zambruno G, Viac J, Panzini H, Thivolet J. Expression of neural tissue markers (S100 protein and Leu7 antigen) by sweat-gland tumours of the skin. J Am Acad Detmatol 1987;17:187-91.
35. Katsumata M, Ezoe K. Immunohistochemical study of lysozyme in various benign sweat apparatus tumors. J Dermatol 1990;17:307-11.
36. Narvaez D, Kanitakis J, Faure M, Claudy A. Bcl-2 oncoprotein expression in sweat gland tumors of the skin. Eur J Dermatol 1996;6:307-10.
37. Kanitakis J, Cozzani E. La maladie de Paget mammaire et extramammaire. In: Encycl Méd Chir (Paris-France), Dermatologie 1994;12-755-A10.
38. Kohler S, Smoller B. Gross Cystic Disease Fluid Protein 15 reactivity in extramammary Paget's disease with and without associated internal malignancy. Am J Dermatopathol 1996; 18:118-23.
39. Goldblum J, Hart W. Vulvar Paget's disease: a clinicopathologic and immunohistochemical study of 19 cases. Am J Surg Pathol 1997;21:1178-87.
40. Kanitakis J, Zambruno G, Viac J, Thivolet J. Involucrin expression in adnexal skin tumours. An immunohistochemical study. Virchows Arch (Pathol Anat) 1986;408:527-40.
41. Schulz T, Hartschuh W. Merkel cells are absent in basal cell carcinomas but frequently found in trichoblastomas. An immunohistochemical study. J Cutan Pathol 1997;24:14-24.
42. Metze D, Soyer HP, Zelger B et al. Expression of a glycoprotein of the carcinoembryonic antigen family in normal and neoplastic sebaceous glands. J Am Acad Dermatol 1996;34:735-44.
43. Kanitakis J, Al-Rifai I, Faure M, Claudy A. T (Thomsen-Friedenreich) and Tn immunoreactivity in normal skin and in benign cutaneous tumors. Acta Derm Venereol, 1998,78.
44. Wick M, Cooper P, Swanson P, Kaye V, Sun TT. Microcystic adnexal carcinoma: an immunohistochemical comparison with other cutaneous appendage tumors. Arch Dermatol 1990;126:189-94.
45. Chan J, Suster S, Wenig B, Tsang W, Chan J, Lau A. Cytokeratin 20 immunoreactivity distinguishes Merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas of various sites. Am J Surg Pathol 1997;21:226-34.
46. Gould V, Moll R, Moll I, Lee I, Franke W. Neuroendocrine (Merkel cells) of the skin: hyperplasias, dysplasias, and neoplasms. Lab Invest 1985;52:334-53.
47. Moll I, Gillardon F, Waltering S, Schmelz M, Moll R. Differences of bcl-2 protein expression between Merkel cels and Merkel cell carcinomas. J Cutan Pathol 1996;23:109-17.
48. Cerroni L, Soyer P, Kerl H. Expression of bcl-2 protein (bcl-2) in cutaneous neoplasms: an immunohistochemical study of 259 benign and malignant tumours of the skin. Eur J Dermatol 1995;5:619-24.
49. Van Nguyen A, Argenyi Z. Cutaneous neuroblastoma. Peripheral neuroblastoma. Am J Dermatopathol 1993;15:7-14.
50. Paul E, Cochran A. Immunohistochemical demonstration of S100 protein and melanoma-associated antigens in melanocytic nevi. J Cutan Pathol 1988;15:161-5.
51. Isobe T, Ichimori K, Nakajima T, Okuyama T. The alpha subunit of S100 protein is present in tumor cells of human malignant melanoma but not in Schwannoma. Brain Res 1984;294:381-4.
52. Nakajima T, Watanabe S, Sato Y, Kameya T, Shimosato Y, Isobe T. Immunohistochemical demonstration of S100 protein in malignant melanoma and pigmented nevus, and its diagnostic application. Cancer 1982;50:912-8.
53. Böni R, Heizmann C, Dogouglu A, Ilg E, Schafer B, Dummer R, Burg G. Ca2+- binding proteins S100A6 and S100B in primary cutaneous melanoma. J Cutan Pathol 1997;24:76-80.
54. Kahn H, Marks A, Thom H, Baumal R. Role of antibody to S100 protein in diagnostic pathology. Am J Clin Pathol 1983;79:341-7.
55. Bacchi C, Bonetti F, Pea M, Martignoni G, Gown A. HMB45. Appl Immunohistochem 1996;4:73-85.
56. Skelton H, Smith K, Barrett T et al. HMB-45 staining in benign and malignant melanocytic lesions: a reflection of cellular activation. Am J Dermatopathol 1991;13:543-50.
57. Wick M, Swanson P, Rocamora A. Recognition of malignant melanoma by monoclonal antibody HMB-45: an immunohistochemical sstudy of 200 paraffin-embedded cutaneous tumors. J Cutan Pathol 1988;15:201-7.
58. Kanitakis J, Hermier C, Chouvet B, Thivolet J. Reactivity of HMB-45 monoclonal antibody with sweat-gland tumours of the skin. Acta Derm Venereol (Stockh) 1991;71:426-8.
59. Smoller B. Immunohistochemistry in the diagnosis of melanocytic neoplasms. Pathology 1994:2:371-83.
60. Prieto V, McNutt S, Lugo J, Reed J. The intermediate filament peripherin is expressed in cutaneous melanocytic lesions. J Cutan Pathol 1997;24:145-50.
61. Kanitakis J, Montazeri A, Ghohestani R, Faure M, Claudy A. Bcl-2 oncoprotein expression in benign nevi and malignant melanomas of the skin. Eur J Dermatol 1995;5:501-7.
62. Zarbo R, Gown A, Nagle R et al. Anomalous cytokeratin expression in malignant melanoma: one- and two-dimensional western blot analysis and immunohistochemical survey of 100 melanomas. Mod Pathol 1990;3:494-501.
63. Kanitakis J. The immunohistochemical differentiation of malignant melanomas from benign naevi. Eur J Dermatol 1994;4:262.
64. Cerio R, Spaull J, Oliver G et al. A study of factor XIIIa and Mac387 immunolabeling in normal and pathological skin. Am J Dermatopathol 1990;12:221-33.
65. Rudolph P, Schubert B, Wacker H et al. Immunophenotyping of dermal spindle-cell tumors: diagnostic value of monocyte marker Ki-M1p and histogenetic considerations. Am J Surg Pathol 1997;21:791-800.
66. Altman D, Nickoloff B, Fivenson, D. Differential expression of factor XIIIa and CD34 in cutaneous mesenchymal tumors. J Cutan Pathol 1993;20:154-8.
67. Abenoza P, Lillemoe T. CD34 and factor XIIIa in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans. Am J Dermatopathol 1993;15:429-34.
68. Kanitakis J, Moayed J, Hoyo E, Schmitt D. Expression of the Human Progenitor Cell Antigen (CD34) in skin tumours. Eur J Dermatol 1994;4:53-7.
69. Prieto V, Reed J, Shea C. CD34 immunoreactivity distinguishes between scar tissue and residual tumor in reexcisional specimens of dermatofibrosarcoma protuberans. J Cutan Pathol 1994;21:324-9.
70. Salloum H, Kanitakis J, Chouvet B, Grimand P, Claudy A. Tumeur desmoïde extraabdominale. Ann Dermatol Venereol 1993;123:685-8.
71. Westra W, Gerald W, Rosai J. Solitary fibrous tumor. Consistent CD34 immunoreactivity and occurrence in the orbit. Am J Surg Pathol 1994;18:992-8.
72. Smith M, Costa M, Weiss S. Evaluation of CD68 and other histiocytic antigens in angiomatoid malignant fibrous histiocytoma. Am J Surg Pathol 1991;15:757-63.
73. Zeiger B, Weinlich G, Steiner H, Zeiger B, Egart-Vigl E. Dermal and subcutaneous variants of plexiform fibrohistiocytic tumor. Am J Surg Pathol 1997;21:235-41.
74. Berti E et al. Lymphomas and Histiocytoses. In: Kanitakis J, Vassileva S, Woodley D (eds) Diagnostic Immunohistochemistry of the Skin. Chapman & Hall Med., London, 1998, 260-78.
75. Willemze R, Kerl H, Sterry W et al. EORTC classification for primary cutaneous lymphomas. Consensus repost of the cutaneous lymphoma study group. Blood 1997;90:354-71.
76. Kurtin P, Pinkus G. Leucocyte common antigen-a diagnostic discriminant between haematopoietic and non-haematopoietic neoplasms in paraffin sections using monoclonal antibodies. Hum Pathol 1985;16:353-65.
77. Cerroni L, Volkenandt M, Rieger E, Soyer H, Kerl H. bcl-2protein expression and correlation with the interchromosomal 14;18translocation in cutaneous lymphomas and pseudolymphomas. J Invest Dermatol 1994;102:231-5.
78. Krenacs L, Tiszalvicz L, Krenacs T, Boumsell L. Immunohistochemical detection of CD1 a antigen in formalin-fixed and paraffinembedded tissue sections with monoclonal antibody 010. J Pathol 1993;171:99-104.
79. Miettinen M, Lindenmayer E, Chaubal A. Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens-evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor. Mod Pathol 1994;7:82-9.
80. Traweek S, Kandalaft P, Mehta P et al. The human haematopoietic progenitor cell antigen (CD34) in vascular neoplasia. Am J Clin Pathol 1991;96:25-31.
81. Sehested M, Hou-Jensen K. Factor VIII-related antigen as an endothelial cell marker in benign and malignant diseases. Virchow's Archiv A (Pathol Anat) 1981;391:217-25.
82. Orchard G, Zeiger B, Wilson-Jones E, Jones R. An immunocytochemical assessment of 19 cases of cutaneous angiosaecoma. Histopathology 1996;28:235-40.
83. Gray H, Rosenberg A, Dickersin G, Bhan A. Cytokeratin expression in epithelioid vascular neoplasms. Hum Pathol 1990;21:212-7.
84. Russell-Jones R, Orchard G, Zeiger B, Wilson-Jones E. Immunostaining for CD31 and CD34 in Kaposi sarcoma. J Clin Pathol 1995;48:1011-6.
85. Kanitakis J, Narvaez D, Claudy A. Expression of the CD34 antigen distinguishes Kaposi's sarcoma from pseudo-Kaposi's sarcoma (acroangiodermatitis). Br J Dermatol 1996;134:44-6.
86. Kanitakis J, Bendelac A, Marchand C, Rigot-Muller G, Thivolet J. Stewart-Treves syndrome: an histogenetic (ultrastructural and immunohistological) study. J Cutan Pathol 1986;13:30-9.
87. Appleton M, Attanoos R, Jasani B. Thrombomodulinas a marker of vascular and lymphatic tumours. Histopathology 1996;29:153-7.
88. Molina A, Lombard C, Donlon T, Bangs C, Dorfman R. Immunohistochemical and cytogenetic studies indicate that malignant angioendotheliomatosis is a primary intravascular (angiotropic) lymphoma. Cancer 1990;66:474-9.
89. Kaye V, Dehner L. Cutaneous glomus tumor. A comparative immunohistochemical study with pseudoangiomatous intradermal melanocytic nevi. Am J Dermatopathol 1991;13:2-6.
90. Azumi N, Ben-Ezra J, Battifora H. Immunophenotypic diagnosis of leiomyosarcoma and rhabdomyosarcoma with monoclonal antibody to muscle actin and desmin in formalin-fixed tissue. Mod Pathol 1988;1:469-74.
91. Tsukada T, McNutt S, Ross R et al. HHF35, a muscle actin-speciflc monoclonal antibody. II: reactivity in normal, reactive and neoplastic tissues. Am J Pathol 1987;127:389-402.
92. Miettinen M. Antibodies specific to muscle actins in the diagnosis and classification of soft tissue tumors. Am J Pathol 1988;30:205-15.
93. Ragdaeng S, Truong L. Comparative immunohistochemical staining for desmin and muscle-specific actin: a study of 576 cases. Am J Clin Pathol 1991;96:32-45.
94. Osborn M, Hill C, Altmansberger M, Weber K. Monoclonal antibodies to titin in conjunction with antibodies to desmin separate rhabdomyosarcoma from other tumor types. Lab Invest 1986;55:101-8.
95. Soini Y, Pääkkö P. Bcl-2 is preferentially expressed in tumours of muscle origin but is not related to p53 expression. Histopathology 1996;28:141-5.
96. Weiss S, Langloss J, Enzinger F. Value of S100 protein in the diagnosis of soft tissue tumors with particular reference to bening and malignant Schwann cell tumors. Lab Invest 1983;49:299-308.
97. Penneys N, Mogollan R, Kowalczyk A, Nadji M, Adachi K. A survey of cutaneous neural lesions for the presence of myelin basic protein. Arch Dermatol 1984;120:210-3.
98. Gray M, Rosenberg A, Dickersin G et al. Glial Fibrillary Acidic Protein and keratin expression by benign and malignant nerve sheath tumors. Hum Pathol 1989:20:1089-96.
99. Cribier B, Grosshans E. Tumeurs cutanées nerveuses rares. Ann Dermatol Venereol 1997;124:280-95.
100. Gray M, Smoller B, McNutt N, Hsu A. Neurofibromas and neurotized melanocytic nevi are immunohistochemically distinct neoplasms. Am J Dermatopathol 1990;12:234-41.
101. Weiss S, Nickoloff B. CD34 is expressed by a distinctive cell population in peripheral nerve, nerve sheath tumours and related lesions. Am J Surg Pathol 1993;17:1039-45.
102. Gray M, Smoller B, McNutt N, Hsu A. Immunohistochemical demonstration of factor XIIIa in neurofibromas. Arch Dermatol, 1990; 126:472-6.
103. Kanitakis J, Mauduit G, Viac J, Thivolet J. Tumeur à cellules granuleuses (Abrikossoff). Etude immunohistologique de 4 cas avec revue de la littérature. Ann Venereol Venereol, 1985;112:871-6.
104. Kanitakis J, Hermier C, Frappaz A, Guillaud V, Thivolet J. Schwannome malin. Identification ultrastructurale et immunohistologique. Ann Dermatol Venereol 1987;114:1407-11.
105. Suster S, Fisher C. Immunoreactivity for the human hepatopoietic progenitor cell antigen (CD34) in lipomatous tumors. Am J Surg Pathol, 1997;21:195-200.
106. Nakamura Y, Becker L, Marks A. S100 protein in tumors of cartilage and bone: an immunohistochemical study. Cancer 1983;52:1820-4.
107. Nemeth A, Penneys S, Bernstein H. Fibrous papule: a tumor of fibrohistiocytic cells that contain factor XIIIa. J Am Acad Dermatol, 1988;19:1102-6.
108. Botella R, MacKie R. Cutaneous lymphadenoma: a case report and review of the literature. Br J Dermatol, 1993;128:339-41.
109. Persson S, Kindblom L, Angervall B. Epithelioid sarcoma. An electron- microscopic and immunohistochemical study. Appl Pathol, 1988;6:1-16.
110. Lucas D, Nascimiento A, Sim H. Clear cell sarcoma of soft tissues. Am J Surg Pathol, 1992;16:1197-204.
111. Argenyi S, Schelper R, Balogh K. Pigmented neuroectodermal tumor of infancy. A light microscopic and immunohistochemical study. J Cutan Pathol, 1991;18:40-5.
112. Sexton C, White W. Primary cutaneous Ewing's family sarcoma. Report of a case with immunostaining for glycoprotein p 30/32 mic2. Am J Dermatopathol 1996;18:601-5.
113. Parham D, Weeks D, Beckwith J. The clinicopathologic spectrum of putative extrarenal rhabdoid tumors. An analysis of 42 cases studied with immunohistochemistry and/or electron microscopy. Am J Surg Pathol 1994;18:1010-29.
114. Hermanns-Lee T, Nikkels A, Ammar A, Pierard-Franchimont C, Piérard G. Vimentinoma, an unusual neoplasm of the skin. Dermatology 1994;189:84-6.
115. Marcoval J, Moreno A, Graells J et al. Angiogenesis and malignant melanoma. Angiogenesis is related to the development of vertical (tumorigenic) growth phase. J Cutan Pathol 1997;245:212-8.
116. Yu CC, Filipe M. Update on proliferation-associated antibodies applicable to formalin-fixed paraffin-embedded tissue and their clinical applications. Histochem J 1993;25:843-53.
117. Gattoretti G, Becker M, Key G et al. Monoclonal antibodies against recombinant parts of the Ki67 antigen (MIB1and MIB3) detect proliferating cells in microwaved-processed formalin-fixed paraffin sections. J Pathol 1992;168:357-63.
118. Hall P, Levison D, Woods A et al. Proliferating Cell Nuclear Antigen (PCNA) immunolocalisation in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 1990;162:285-294.
119. WAF/CIP1 expression in non-melanoma skin tumors. J Cutan Pathol 1997;24:223-7.
120. Wick M. Oncogene analysis in diagnostic pathology: a current perspective. Am J Clin Pathol 1992;97:S1-3.
121. Ramsay J, From L, Iscoe N, Kahn H. MIB-1 proliferative activity is a significant prognostic factor in primary thick cutaneous melanomas. J Invest Dermatol 1995;105:22-6.
122. Böni R, Doguoglu A, Burg G, Müller B, Dummer R. MIB-1 immunoreactivity correlates with metastatic dissemination in primary thick cutaneous melanoma. J Am Acad Dermatol 1996;35:416-8.
123. Talve L, Collan Y, Ekfors T. Nuclear morphometry, immunohistochemical staining with Ki67 antibody and mitotic index in the assessment of proliferative activity and prognosis of primary malignant melanomas of the skin. J Cutan Pathol 1996;23:335-43.
124. Woosley J, Dietrich D. Prognostic significance of PCNA grade in malignant melanoma. J Cutan Pathol 1993;20:498-503.
125. van den Oord J, Macs A, Stas M, Nuyts J, Battocchio S, Kasran A, Garmyn M, De Wever I, De Wolf-Peters C. CD40 is a prognostic marker in primary cutaneous malignant melanoma. Am J Pathol 1996;149:1953-61.
126. Kanitakis J, Euvrard S, Bourchany D, Faure M, Claudy A. Expression of the nm23 gene product in skin tumours. J Cutan Pathol 1997;24:151-6.
127. Weiss J, Heine M, Körner B, Pilch H, Jung E. Expression of p53 protein in malignant melanoma: clinicopathologic and prognostic implications. Br J Dermatol 1995;133:23-31.
128. Healy E, Angus B, Lawrence C, Rees J. Prognostic value of Ki67 antigen expression in basal cell carcinomas. Br J Dermatol 1995;133:737-41.
129. Kanitakis J, Narvaez D, Euvrard S, Faure M, Claudy A. Proliferation markers Ki67 and PCNA in cutaneous squamous cell carcinomas: lack of prognostic value. Br J Dermatol 1997;136:643-4.
130. Onodera H, Nakamura S, Sugai T. Cell proliferation and p53 protein expression in cutaneous epithelial neoplasms. Am J Dermatopathol 1996;18:580-8.
131. Mansoor A, McKee P, Simpson J, McGuire B, Hobbs C. Prognostic significance of Ki67 and p53 immunoreactivity in cutaneous squamous cell carcinomas. Am J Dermatopathol 1996;18:351-7.
132. Hasebe T, Mukai K, Ishihara K, Kaneko A, Shimosato Y. Sebaceous and sweat gland carcinomas of the skin. Clinicopathological study and significance of c-erbB-2 oncoprotein expression. Acta Pathol Jpn 1992:42:585-94.
133. Penneys N, Shapiro S. CD44expression in Merkel cell carcinoma may correlate with risk of metastasis. J Cutan Pathol 1994;21:22-6.
134. Harwood C, Green M, Cook M. CD44 expression in melanocytic lesions: a marker of malignant progression? Br J Dermatol 1996;135:876-82.
135. Manten-Horst E, Danen E, Smit L et al. Expression of CD44 splice variants in human cutaneous melanoma and melanoma cell lines is related to tumor progression and metastatic potential. Int J Cancer 1995;64:182-8.
136. Seelentag W, Günthert U, Saremaslani P et al. CD44 standard and variant isoform expression in human epidermal skin tumours is not correlated with tumour aggressiveness but down-regulated during proliferation and tumour de-differentiation. Int J Cancer 1996;69:218-24.
137. Guttinger M, Sutti F, Barnier C, Mackay C, Berti E. Expression of CD44 standard and variant forms in skin tumours. Loss of CD44 correlates with aggressive potential. Eur J Dermatol 1995;5:398-405.
138. Sy MS, Mori H, Liu D. CD44 as a marker in human cancers. Curr OpOncol 1997;9:108-12.
139. Wallace M, Longacre T, Smoller B. Estrogen and progesterone receptors and anti-gross cystic disease fluid protein 15 (BRST-2) fail to distinguish metastatic breast carcinoma from eccrine neoplasms. Mod Pathol 1995;8:897-901.
140. Tsubura A, Senzaki H, Saski M et al. Immunohistochemical demonstration of breast-derived and/or carcinoma-associated glycoproteins in normal skin appendages and their tumors. J Cutan Pathol 1992;19:73-9.
141. Moulin G, Balme B, Frappait L. L'adénomatose érosive du mamelon. A propos de 10 cas avec étude immunohistochimique. Ann Dermatol Venereol 1990;117:537-45.
142. Kanitakis J, Al-Rifai I, Faure M, Claudy A. Differential expression of T (Thomsen-Friedenreich) and Tn antigens in primary and metastatic carcinomas of the skin (soumis).
143. Toyota N, Asaga H, Hirokawa M, Iizuka H. A case of skin metastasis from follicular thyroid carcinoma. Dermatology 1994; 188:69-71.